drugset / Trial / NCT04741477
The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
Phase 1
Completed
47 enrolled
Johns Hopkins University
Substance Abuse and Mental Health Services Administration (SAMHSA) · collab
RandomizedParallel-groupDouble-blindBasic science
Summary
This study will evaluate the pharmacokinetic and pharmacodynamic effects of hemp-based Cannabidiol (CBD) topical products (e.g., lotions, creams, patches) that contain low levels of delta-9-tetrahydrocannabinol (THC).
Timeline
- Start
- 2021-07-14
- Primary completion
- 2022-09-16
- Completion
- 2022-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | — | Topical |
| Subject | delta-9-tetrahydrocannabinol | Other / unclassified | — | Topical |
Indications
No indication recorded.